These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23371333)

  • 21. Two-stage liver resection and chemotherapy for bilobar colorectal liver metastases.
    Garcea G; Polemonivi N; O'Leary E; Lloyd TD; Dennison AR; Berry DP
    Eur J Surg Oncol; 2004 Sep; 30(7):759-64. PubMed ID: 15296990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases.
    Hosokawa I; Allard MA; Gelli M; Ciacio O; Vibert E; Cherqui D; Sa Cunha A; Castaing D; Miyazaki M; Adam R
    Ann Surg Oncol; 2016 Jun; 23(6):1897-905. PubMed ID: 26822881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients.
    Shen P; Thai K; Stewart JH; Howerton R; Loggie BW; Russell GB; Levine EA
    Ann Surg Oncol; 2008 Dec; 15(12):3422-32. PubMed ID: 18784963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
    Schimanski CC; Möhler M; Schön M; van Cutsem E; Greil R; Bechstein WO; Hegewisch-Becker S; von Wichert G; Vöhringer M; Heike M; Heinemann V; Peeters M; Kanzler S; Kasper S; Overkamp F; Schröder J; Seehofer D; Kullmann F; Linz B; Schmidtmann I; Smith-Machnow V; Gockel I; Lang H; Galle PR
    BMC Cancer; 2012 Apr; 12():144. PubMed ID: 22494623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Mackillop WJ
    JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
    Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
    Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal treatment options for bilobar colorectal liver metastases.
    Homayounfar K; Liersch T; Niessner M; Meller J; Lorf T; Becker H; Ghadimi BM
    Langenbecks Arch Surg; 2010 Aug; 395(6):633-41. PubMed ID: 20213463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.
    Takahashi T; Shibata Y; Tojima Y; Tsuboi K; Sakamoto E; Kunieda K; Matsuoka H; Suzumura K; Sato M; Naganuma T; Sakamoto J; Morita S; Kondo K
    Int J Clin Oncol; 2013 Apr; 18(2):335-42. PubMed ID: 22383023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal carcinoma with potentially resectable metastases: factors associated with the failure of curative schedule.
    Fuks D; Cook MC; Bréhant O; Henegar A; Dumont F; Chatelain D; Yzet T; Mulieri G; Joly JP; Nguyen-Khac E; Dupas JL; Mauvais F; Verhaeghe P; Regimbeau JM
    Gastroenterol Clin Biol; 2008 Apr; 32(4):390-400. PubMed ID: 18406091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after repeat resection of liver metastases from colorectal cancer.
    Neeff HP; Drognitz O; Holzner P; Klock A; Bronsert P; Hopt UT; Makowiec F
    Int J Colorectal Dis; 2013 Aug; 28(8):1135-41. PubMed ID: 23468250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Cure Possible After Sequential Resection of Hepatic and Pulmonary Metastases From Colorectal Cancer?
    Rajakannu M; Magdeleinat P; Vibert E; Ciacio O; Pittau G; Innominato P; SaCunha A; Cherqui D; Morère JF; Castaing D; Adam R
    Clin Colorectal Cancer; 2018 Mar; 17(1):41-49. PubMed ID: 28709876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
    Rouyer M; Smith D; Laurent C; Becouarn Y; Guimbaud R; Michel P; Tubiana-Mathieu N; Balestra A; Jové J; Robinson P; Noize P; Moore N; Ravaud A; Fourrier-Réglat A;
    Target Oncol; 2016 Feb; 11(1):83-92. PubMed ID: 26298481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
    Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
    J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.